Amedisys, Inc. logo

Amedisys, Inc. (AMED)

Delisted
14 Aug 2025
NASDAQ (NGS) NASDAQ (NGS)
$
100. 99
+0.01
+0.0099%
Pre Market
$
102. 00
+1.01 +1.0001%
3.32B Market Cap
1,184.88 P/E Ratio
- Div Yield
1.04M Volume
4.38 Eps
$ 100.98
Previous Close
Investors:
Day Range
100.93 101.02
Year Range
82.15 101.02
Want to track AMED and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

AMED Chart

Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors

Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors

AMED's planned merger with UnitedHealth remains on the rocks with regulatory overhang still an issue. The deal is also asymmetrically weighted in UNH's favor, with the latter up for no penalty if it fails. Not so for AMED. Aside from this, there are internal factors dragging on AMED's business performance.

Seekingalpha | 1 year ago
Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?

Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings

Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 year ago

Amedisys, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
JM
John Malone Amundi
195,993 $48,004 $48,004 - -
Bruce Barton
Bruce Barton Parkworth Wealth Management, Inc.
4 $386.5 $364 -$22.5 -5.82%
Guillaume Binnendijk
Guillaume Binnendijk Cigogne Management SA
29,649 $2.69M $2.69M - -

Amedisys, Inc. (AMED) FAQ

What does "Delisted" mean?

Amedisys, Inc. has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

No dividend payments were recorded prior to delisting.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

The last recorded stock split occurred on Dec 05, 2006 with a ratio of 4:3.

What was the last known trading price?

The stock last traded at $100.99 on Aug 14, 2025 before being delisted.

Amedisys, Inc. Profile

- Industry
- Sector
Richard M. Ashworth CEO
NASDAQ (NGS) Exchange
023436108 CUSIP
US Country
19,000 Employees
- Last Dividend
5 Dec 2006 Last Split
17 Aug 1994 IPO Date

Overview

Amedisys, Inc., a healthcare service provider based in the United States, operates nationally with a focus on delivering personalized home health, hospice, and high acuity care. Established in 1982 and headquartered in Baton Rouge, Louisiana, the company has evolved to meet the needs of patients across three primary segments. Aimed at enhancing the healthcare delivery system, Amedisys, Inc. utilizes a comprehensive approach that revolves around delivering specialized care directly to patients' homes, thereby personifying its mission to maintain and improve the quality of life for those under its care.

Products and Services

  • Home Health

    This segment provides a wide variety of services including post-surgery recovery, chronic disability management, and terminal illness care, directly in the comfort of the patient's home. To prevent unnecessary hospital readmissions, Amedisys utilizes skilled nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, and social workers. This multidisciplinary approach ensures comprehensive care tailored to each patient's unique needs.

  • Hospice

    Aimed at offering comfort and support to individuals facing terminal illnesses such as cancer, heart disease, pulmonary disease, or Alzheimer's, this segment focuses on palliative care. The hospice care by Amedisys is designed to alleviate pain and make the patient's remaining time as meaningful and comfortable as possible, involving family and loved ones in the care process.

  • High Acuity Care

    This segment offers care similar to that which is provided in an inpatient hospital or skilled nursing facility, but in the patient's home. It includes essential elements of both settings and is enhanced with palliative care services. The high acuity care model is an innovative approach to treating patients with complex medical needs, enabling them to receive high-level care in their familiar surroundings.

Contact Information

Address: 3854 American Way
Phone: 225 292 2031